D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.32% |
| 2 | Healthcare | 8.96% |
| 3 | Financials | 7.81% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Zymeworks
ZYME
$1.68B
| $2.9M | ﹤0.01% |
369,187
+280,710
| +317% | +$1.97M |
|
|
FZT
2477
DELISTED
FAST Acquisition Corp. II
FZT
| $2.9M | ﹤0.01% |
289,467
+33,500
| +13% | +$332K |
|
|
VTYX
2478
DELISTED
Ventyx Biosciences
VTYX
| $2.9M | ﹤0.01% |
88,359
-84,371
| -49% | -$2.5M |
|
|
SWIR
2479
CALL
DELISTED
Sierra Wireless
SWIR
| $2.9M | ﹤0.01% |
100,000
| – | – |
|
2480
CALL
Toll Brothers
TOL
$14.3B
| $2.88M | ﹤0.01% |
57,700
| – | – |
|
|
INTE
2481
DELISTED
Integral Acquisition Corporation 1 Class A Common Stock
INTE
| $2.88M | ﹤0.01% |
284,728
| – | – |
|
2482
TriMas Corp
TRS
$1.45B
| $2.87M | ﹤0.01% |
103,508
-5,826
| -5% | -$156K |
|
2483
AZZ Inc
AZZ
$4.59B
| $2.87M | ﹤0.01% |
71,411
+16,689
| +30% | +$656K |
|
2484
PUT
MGM Resorts International
MGM
$11.7B
| $2.87M | ﹤0.01% |
85,500
+4,400
| +5% | +$152K |
|
2485
PUT
UBS Group
UBS
$175B
| $2.87M | ﹤0.01% |
+153,500
| New | +$2.61M |
|
2486
PACCAR
PCAR
$71.6B
| $2.86M | ﹤0.01% |
43,292
+22,910
| +112% | +$1.5M |
|
|
CSW
2487
CSW Industrials
CSW
$5.69B
| $2.85M | ﹤0.01% |
24,568
-1,397
| -5% | -$167K |
|
2488
PUT
Unity
U
$15.4B
| $2.85M | ﹤0.01% |
99,600
-178,800
| -64% | -$5.6M |
|
2489
Marqeta
MQ
$1.89B
| $2.85M | ﹤0.01% |
116,466
+104,859
| +903% | +$2.86M |
|
2490
CALL
Ormat Technologies
ORA
$6.15B
| $2.85M | ﹤0.01% |
+32,900
| New | +$2.95M |
|
2491
Hanmi Financial
HAFC
$960M
| $2.84M | ﹤0.01% |
114,602
+5,205
| +5% | +$132K |
|
2492
Lindsay Corp
LNN
$1.2B
| $2.83M | ﹤0.01% |
17,365
-5,280
| -23% | -$871K |
|
2493
Surgery Partners
SGRY
$2.05B
| $2.83M | ﹤0.01% |
101,482
+81,100
| +398% | +$2.15M |
|
2494
Owens Corning
OC
$11.7B
| $2.83M | ﹤0.01% |
33,120
-30,970
| -48% | -$2.71M |
|
2495
Flowers Foods
FLO
$1.55B
| $2.82M | ﹤0.01% |
98,287
-58,105
| -37% | -$1.63M |
|
2496
PUT
Weibo
WB
$1.99B
| $2.82M | ﹤0.01% |
147,700
+132,700
| +885% | +$2M |
|
2497
HealthEquity
HQY
$8.78B
| $2.82M | ﹤0.01% |
45,763
-14,648
| -24% | -$984K |
|
2498
CALL
Appian
APPN
$2.09B
| $2.82M | ﹤0.01% |
86,600
+6,600
| +8% | +$260K |
|
2499
West Pharmaceutical
WST
$24.5B
| $2.82M | ﹤0.01% |
11,971
-44,155
| -79% | -$10.5M |
|
2500
Brookdale Senior Living
BKD
$3.4B
| $2.81M | ﹤0.01% |
1,028,404
-298,518
| -22% | -$1.12M |
|
Similar funds
D.E. Shaw & Co's Q4 2022 Portfolio in Review
As of Q4 2022, D.E. Shaw & Co held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
D.E. Shaw & Co's Q4 2022 filing shows 476 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- D.E. Shaw & Co added most to Tesla in Q4 2022, an estimated $826M increase.
- D.E. Shaw & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- D.E. Shaw & Co fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- D.E. Shaw & Co's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- D.E. Shaw & Co opened 476 new positions and closed 783 in Q4 2022.
- D.E. Shaw & Co's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.